18F-FDG PET and PET/CT for the diagnosis of diabetic foot osteomyelitis

Hippokratia

Volumn 17, Issue 1, 2013, Pages 4-6

  Papanas, Nikolaos ^a   Zissimopoulos, A ^a   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

18F FDG PET; Diabetes; Diabetic foot; Osteomyelitis; PET CT

Indexed keywords

CITRATE GA 68; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC FOOT OSTEOMYELITIS; DIAGNOSTIC ACCURACY; EDITORIAL; HUMAN; ISOTOPE LABELING; LEUKOCYTE; NEUROPATHIC JOINT DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SOFT TISSUE INFECTION;

EID: 84879705901     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (36)

1. Kosinski MA, Lipsky BA. Current medical management of diabetic foot infections. Expert Rev Anti Infect Ther. 2010; 8: 1293-1305.
2. Papanas N, Maltezos E. The diabetic foot: established and emerging treatments. Acta Clin Belg. 2007; 62: 230-238.
3. Papanas N, Maltezos E, Edmonds M. Salvation of the diabetic foot: still a quest for the Holy Grail? Vasa. 2011; 40: 267-269.
4. Edmonds ME. The diabetic foot, 2003. Diabetes Metab Res Rev. 2004; 20 Suppl 1: S9-S12.
5. Papanas N, Maltezos E. The diabetic foot: a global threat and a huge challenge for Greece. Hippokratia. 2009; 13: 199-204.
6. Edmonds ME, Foster AVM, Sanders LJ. Stage 4: the infected foot. Edmonds ME, Foster AVM, Sanders LJ, A Practical Manual of diabetic footcare, Blackwell, Oxford, 2004, 102-140.
7. Gardner SE, Hillis SL, Frantz RA. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs. 2009; 11: 119-128.
8. Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev. 2008; 24 Suppl 1: S3-S6.
9. Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008; 24 Suppl 1: S145-S161.
10. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995; 273: 721-723.
11. Lavery LA, Armstrong DG, Peters EJ, Lipsky BA. Probe-tobone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care. 2007; 30: 270-274.
12. Aragón-Sánchez J, Lipsky BA, Lázaro-Martínez JL. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? Diabet Med. 2011; 28: 191-194.
13. Rasli MH, Zacharin MR. Foot problems and effectiveness of foot care education in children and adolescents with diabetes mellitus. Pediatr Diabetes. 2008; 9: 602-608.
14. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med. 2009; 39: 52-65.
15. Papanas N, Zissimopoulos A, Maltezos E. The role of nuclear medicine in the diagnosis of common and specific diabetic infections. Hell J Nucl Med. 2010; 13: 150-157.
16. Sella EJ. Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle Int. 2009; 30: 568-576.
17. Rozzanigo U, Tagliani A, Vittorini E, Pacchioni R, Brivio LR, Caudana R. Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis. Radiol Med. 2009; 114: 121-132.
18. Donovan A, Schweitzer ME. Current concepts in imaging diabetic pedal osteomyelitis. Radiol Clin North Am. 2008; 46: 1105-1124.
19. Whitehouse RW. Radiology and Magnetic Resonance Imaging of the diabetic foot. Boulton AJM, Cavanagh P, Raymann G (Eds), The foot in diabetes, 4th edition, John Wiley and Sons Ltd, Chichester, 2006, 222-237.
20. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009; 39: 36-51.
21. Palestro CJ. 18F-FDG and diabetic foot infections: the verdict is. J Nucl Med. 2011; 52: 1009-1011.
22. Höpfner S, Krolak C, Kessler S, Tiling R, Brinkbäumer K, Hahn K, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004; 25: 890-895.
23. Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O. The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med. 2005; 46: 444-449.
24. Basu S, Chryssikos T, Houseni M, Scot Malay D, Shah J, Zhuang H, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007; 28: 465-472.
25. Schwegler B, Stumpe KD, Weishaupt D, Strobel K, Spinas GA, von Schulthess GK, et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med. 2008; 263: 99-106.
26. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol. 2010; 12: 335-342.
27. Familiari D, Glaudemans AW, Vitale V, Prosperi D, Bagni O, Lenza A, et al. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med. 2011; 52: 1012-1019.
28. Kagna O, Srour S, Melamed E, Militianu D, Keidar Z. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot. Eur J Nucl Med Mol Imaging. 2012; 39: 1545-1550.
29. Gnanasegaran G, Vijayanathan S, Fogelman I. Diagnosis of infection in the diabetic foot using (18)F-FDG PET/CT: a sweet alternative? Eur J Nucl Med Mol Imaging. 2012; 39: 1525-1527.
30. Papanas N, Ziegler D. Polyneuropathy in Impaired Glucose Tolerance: Is Postprandial Hyperglycemia the Main Culprit? A Mini-Review. Gerontology. 2013; 59: 193-198.
31. Gouveri E, Papanas N, Hatzitolios AI, Maltezos E. Hypovitaminosis D and peripheral arterial disease: Emerging link beyond cardiovascular risk factors. Eur J Intern Med. 2012; 23: 674-81.
32. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Vitamin D deficiency, statin-related myopathy and other links with vascular risk. Curr Med Res Opin. 2011; 27: 1691-1692.
33. Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes. 2011; 2: 59-65.
34. Glaudemans AW, Quintero AM, Signore A. PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? Eur J Nucl Med Mol Imaging. 2012; 39: 745-749.
35. Kumar V, Boddeti DK. (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation. Recent Results Cancer Res. 2013; 194: 189-219.
36. Kentikelenis A, Karanikolos M, Papanicolas I, Basu S, McKee M, Stuckler D. Effects of Greek economic crisis on health are real. BMJ. 2012; 345: e8602; author reply e8608.